FindTrial
Sign In

Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.

Status
AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT06025227
Enrollment
Unknown
Registered
2023-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colitis, Ulcerative

Keywords

Ulcerative Colitis

Brief summary

Provide pre-approval single patient Expanded Access (Compassionate Use) of Etrasimod for patients.

Detailed description

In Expanded Access, treating physicians are the Sponsors. Expanded Access requests from treating physicians may be submitted to www.pfizercares.com. Availability will depend on location and country.

Interventions

DRUGEtrasimod

tablets

Sponsors

Pfizer
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

Patient must be intolerant, have a contraindication or had inadequate response to at least 3 therapies available for Ulcerative Colitis (UC) in this country or provide a rationale of why therapy was not used.

Contacts

Primary ContactPfizerCares
PfizerCares@Pfizer.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026